SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/#release
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
In a recent Financial Times article, “PR and news boundaries are being redrawn,” media editor Andrew Edgecliffe-Johnson turns the spotlight on the PR industry using PR Newswire’s transformation as the indicator of the increasing importance of this earned media discipline.
A recent post on Beyond PR, Evolving Media … And Evolving PR, takes a closer look at Edgecliffe-Johnson’s analysis of the changing PR business as well as PR Newswire’s CEO, Ninan Chacko’s, perspective on the emergence of content marketing, its impact on communications and the future of the business.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58545-pr-newswire-ceo-ninan-chacko-on-conversation-with-financial-times
Vi knows the Rule: Girls don’t walk with boys, and they never even think about kissing them. But no one makes Vi want to break the Rules more than Zenn. The Thinkers may have brainwashed the rest of the population, but Vi is determined to think for herself. Learn about the book here, http://bit.ly/nZTOhm Learn about this author here, http://elanajohnson.blogspot.com/ Teen dystopian
